Clinical study protocol template
GINA Global Initiative for Asthma GOLD Global Initiative For Chronic Obstructive Lung Disease H0 null hypothesis Ha alternative hypothesis HbA1c hemoglobin A1c; glycosylated hemoglobin hCG human chorionic gonadotropin HFA hydrofluoroalkane HRQOL health-related quality of life hsCRP high sensitivityC-reactive protein IB investigator brochure
Download Clinical study protocol template
Information
Domain:
Source:
Link to this page:
Documents from same domain
New antibiotic treatment options for uncomplicated ...
clinicaltrials.govtreatment options for gonorrhoea and only a few new drugs in the development pipeline, it is important to test existing antibiotics for their efficacy in gonorrhoea treatment. Objective : This project aims to identify new treatment modalities for uncomplicated gonorrhoea using
A PROSPECTIVE MULTI CENTER RANDOMIZED CONTROLLED …
clinicaltrials.govconjunction with Ceramic on Ceramic and Taperloc Complete Microplastyarticulation stem in primary total hip arthroplasty compared to patients who received the Exceed ABT Acetabular system with the same combination.
Title: A Phase 1, Randomized, Double-Blind, Placebo ...
clinicaltrials.govA Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of TAK-653 in Healthy Subjects Phase 1 TAK-653 Escalating Single and Multiple Dose Study in Healthy Subjects Sponsor: Takeda Development Centre Europe Ltd. 61 Aldwych London, WC2B 4AE United Kingdom
Statistical Analysis Plan (SAP) - ClinicalTrials.gov
clinicaltrials.govstatistical analysis. The subsections below will describe analyses in addition to the descriptive statistics. 6.1 Primary outcome The primary analysis will compare intervention groups (water supplementation vs control treatment) on their mean change in fasting plasma glucose between baseline and 12 months using a linear mixed model.
A Phase II, Randomized, Double -blind, Placebo -controlled ...
clinicaltrials.gov• International Conference on Harmonisation, E6 Good Clinical Practice: Consolidated Guideline. • All applicable laws and regulations, including, without limitation, data privacy laws and regulations. • Regulatory requirements for reporting serious …
Clinical Study Report (CSR) Template (Drug and Device)
clinicaltrials.govATC Anatomical Therapeutic Chemical CFB change from baseline DHA dapsone hydroxylamine eCRF electronic case report form IGA Investigator’s Global Assessment MedDRA Medication Dictionary for Regulatory Activities mITT modified intent-to-treat NAD N-acetyl dapsone PK pharmacokinetic ...
Research Proposal - ClinicalTrials.gov
clinicaltrials.govas fecal microbiota transplantation (FMT). 4. Procedures Tissue samples will be obtained from consenting patients at (SDMCUT), or other relevant facilities (see section 6.i below), in accordance with protocols approved by the University of Texas Institutional Review Board (UTIRB). Patients who meet eligibility criteria will have their
Novartis CSR template
clinicaltrials.gov9.1 Study design Figure 9-1 Study design BID: twice a day, QD: once a day. This was a multicenter, randomized, double-masked, two-arm, placebo-controlled, parallel-group study in patients with normal tension glaucoma who were insufficiently controlled on travoprost 0.004% (Travatan) monotherapy. Approximately 200 patients were planned to be
DETAILED STATISTICAL ANALYSIS PLAN (SAP)
clinicaltrials.govStatistical principles : 4.1. Multiplicity : The diagnostic and prognostic basic stud y and each sub -study consist of one primary outcome and one or more secondary, exploratory outcomes. We will encounter multiplicity issues due to the multiple
Title: TWILIGHT Study - Ticagrelor With Aspirin or Alone ...
clinicaltrials.govPrior stroke Dialysis-dependent renal failure Active bleeding or extreme-risk for major bleeding (e.g. acute ... Life expectancy < 1 year ... 7.3.4 Adverse Events based on signs and symptoms ...
Related documents
Global Initiative for Chronic Disease DISTRIBUTE OR COPY ...
goldcopd.orgGlobal Initiative for Chronic Obstructive Lung Disease Global Initiative for Chronic Obstructive Lung Disease POCKET GUIDE TO COPD DIAGNOSIS, MANAGEMENT, AND PREVENTION A Guide for Health Care Professionals 2018 REPORT COPYRIGHTED MATERIAL- DO NOT COPY OR DISTRIBUTE
GINA DIFFICULT-TO-TREAT & SEVERE ASTHMA
ginasthma.orgchronic obstructive pulmonary disease (COPD). 6. In a Canadian study, severe uncontrolled asthma was estimated to account for more than 60% of asthma costs. 7. Patients with severe asthma and their families also bear a significant financial burden, not only for medical care and medications, but also through lost earnings . and career choices.
Global Initiative for Chronic Disease
goldcopd.orgGlobal Initiative for Chronic Obstructive Lung Disease Global Initiative for Chronic Obstructive Lung Disease POCKET GUIDE TO COPD DIAGNOSIS, MANAGEMENT, AND PREVENTION A Guide for Health Care Professionals 2021 REPORT COPYRIGHT MATERIAL - DO NOT COPY OR DISTRIBUTE
Long-acting beta agonists in Asthma and COPD
nj.govchronic obstructive pulmonary disease (COPD). They work through sustained smooth muscle relaxation and are potent ... The Global Initiative for Asthma (GINA) 2009 guidelines and the National Heart, Lung, and Blood Institute (NHLBI) 2007 asthma guidelines recommend adding LABAs to patients ≥ 12 years
References in AJHP Style - ASHP
www.ashp.orgGlobal Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2015).